Rv1379 Uracil phosphoribosyltransferase (EC 18.104.22.168) / Pyrimidine operon regulatory protein PyrR
|Symbol||Product||Feature Type||Start||End||Strand||Length||AA Length||is TF|
|Rv1379||pyrR||Uracil phosphoribosyltransferase (EC 22.214.171.124) / Pyrimidine operon regulatory protein PyrR||CDS||1552654||1553235||+||582||193||TRUE|
Rv1379 (Uracil phosphoribosyltransferase (EC 126.96.36.199) / Pyrimidine operon regulatory protein PyrR) is predicted to be co-regulated in modules bicluster_0137 with residual 0.49 and bicluster_0484 with residual 0.42.
This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 850.00 and 1,200.00 for bicluster_0137 and 270.00 and 200.00 for bicluster_0484 respectively.
These modules are enriched for following go terms: 'de novo' pyrimidine nucleobase biosynth..., pyrimidine-containing compound biosynthe..., pyrimidine-containing compound metabolic..., organonitrogen compound metabolic proces..., nucleobase-containing small molecule met..., carbon-nitrogen ligase activity, with gl... .
This gene is found to be for growth on cholesterol.
|Gene Target||Differential Expression||Distance||Expression||pvalue||Type|
|Product (LegacyBRC)||Product (RefSeq)|
|Bifunctional protein pyrR||bifunctional pyrimidine regulatory protein PyrR uracil phosphoribosyltransferase|
|928||- - - - - -|
|BioCyc Gene Page||Cellular Overview Map|
|t-test p-value||Cholesterol/Glycerol Ratio|
How essentiality calculations were done?
The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.
reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.